Cite
HARVARD Citation
Migliaccio, I. et al. (2021). CDK4/6 inhibitors: A focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive HER2-negative breast cancer. Cancer treatment reviews. p. . [Online].